David M Lockhart

age ~70

from Hillsborough, NJ

Get Report

Connected to:

David Lockhart Phones & Addresses

Hillsborough, NJ
Three Bridges, NJ
Plainsboro, NJ
Saint Regis Falls, NY
Waverly, NY
Brewster, MA
Bonita Springs, FL
Asbury Park, NJ
Franklin, NY
Massena, NY
Neshanic Station, NJ
1130 River Rd, Hillsborough, NJ 08844 • 9087231858

Work

Company:

Amicus therapeutics, inc.
Address:

6 Cedarbrook Dr, East Windsor, NJ 08512
Phones:

6096622000
Position:

Chief scientific officer
Industries:

Pharmaceutical Preparations

Education

Degree:

High school graduate or higher

Emails

x***[email protected]

Name / Title

Company / Classification

Phones & Addresses

Mr. David Lockhart
Owner

Lockhart Truck Center
Lockhart Truck Centre
Truck Dealers

100 Thornhill Drive, Dartmouth, NS B3B 1S3
9024685900, 9024687490

Mr. David Lockhart
General Manager

East Coast International Trucks - Moncton
Auto Dealers - Used Cars

100 Urquhart Avenue, Moncton, NB E1H 2R5
5068572864

Mr. David Lockhart
Owner

Lockhart's Tree Service
Tree Services

1811 12th St., #B, Lawrenceville, IL 62439
6189433973

David Lockhart
Chief Scientific Officer

Amicus Therapeutics, Inc.
Pharmaceutical Preparations

6 Cedarbrook Dr, East Windsor, NJ 08512

David Lockhart
Owner

Lockhart Truck Center
Truck Dealers

9024685900, 9024687490

David Lockhart
General Manager

East Coast International Trucks - Moncton
Auto Dealers - Used Cars

5068572864

David Lockhart

LOCKHART AUTOMOTIVE LLC

Lawyers & Attorneys

David James Lockhart - Lawyer

view source

Licenses:

Montana - Active 2009

David A Lockhart - Lawyer

view source

Licenses:

Dist. of Columbia - Legal Consultant 2003

Medicine Doctors

David W. Lockhart

view source

Specialties:

Family Medicine

Work:

Family Medicine AssociatesBlessing Physician Services
927 Broadway St STE 302, Quincy, IL 62301
2172246423 (phone), 2172215581 (fax)

Education:

Medical School
Indiana University School of Medicine
Graduated: 1976

Procedures:

Arthrocentesis
Destruction of Benign/Premalignant Skin Lesions
Skin Tags Removal
Vaccine Administration

Conditions:

Acute Conjunctivitis
Anxiety Dissociative and Somatoform Disorders
Atrial Fibrillation and Atrial Flutter
Bronchial Asthma
Chronic Renal Disease

Languages:

English
Spanish

Description:

Dr. Lockhart graduated from the Indiana University School of Medicine in 1976. He works in Quincy, IL and specializes in Family Medicine. Dr. Lockhart is affiliated with Blessing Hospital.

Us Patents

Therapy Regimens, Dosing Regimens And Stable Medicaments For The Treatment Of Pompe Disease
view source
US Patent:

20100119502, May 13, 2010
Filed:

Nov 11, 2009
Appl. No.:

12/616670
Inventors:

Hung V. Do - New Hope PA, US
Ken Valenzano - East Brunswick NJ, US
David J. Lockhart - Del Mar CA, US
Assignee:

AMICUS THERAPEUTICS, INC. - Cranbury NJ
International Classification:

A61K 38/47
A61P 43/00
US Classification:

424 9461
Abstract:

The present application provides a method for treating Pompe disease in a subject in need thereof, that includes a method of administering to the subject a GAA enzyme in combination with an ASSC for the GAA enzyme. The present application also provides methods for increasing the in vitro and in vivo stability of a GAA enzyme formulation.

Dosing Regimens For The Treatment Of Lysosomal Storage Diseases Using Pharmacological Chaperones
view source
US Patent:

20100266571, Oct 21, 2010
Filed:

Apr 28, 2008
Appl. No.:

12/597238
Inventors:

David Lockhart - Cranbury NJ, US
Brandon Wustman - Princeton NJ, US
Assignee:

AMICUS THERAPEUTICS, INC. - Cranbury NJ
International Classification:

A61K 38/47
A61K 31/445
A61K 31/70
A61K 31/713
A61P 25/16
A61P 25/28
A61P 7/06
US Classification:

424 9462, 514315, 514 43, 514 44 R
Abstract:

The present invention provides dosing regimens for administering pharmacological chaperones to a subject in need thereof. The dosing regimens can be used to treat disorders caused by improper protein misfolding, such as lysosomal storage disorders.

Therapy Regimens, Dosing Regimens And Stable Medicaments For The Treatment Of Pompe Disease
view source
US Patent:

20110268721, Nov 3, 2011
Filed:

May 11, 2011
Appl. No.:

13/105720
Inventors:

Hung V. Do - New Hope PA, US
Ken Valenzano - East Brunswick NJ, US
David J. Lockhart - Solana Beach CA, US
Assignee:

Amicus Therapeutics, Inc. - Cranbury NJ
International Classification:

A61K 38/47
A61P 3/00
US Classification:

424 9461
Abstract:

The present application provides a method for treating Pompe disease in a subject in need thereof, that includes a method of administering to the subject a GAA enzyme in combination with an ASSC for the GAA enzyme. The present application also provides methods for increasing the in vitro and in vivo stability of a GAA enzyme formulation.